IBD and Obesity Increases Odds of Treatment Failure in Anti-TNF Therapy
4.9
$ 22.99
In stock
(546)
Product Description
Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort - Thomas Greuter, Frédéric Porchet, Manuel B Braga-Neto, Jean-Benoit Rossel, Luc
Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes
Proposed management algorithm for secondary loss of response to
Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD
COVID-19 therapeutics: Challenges and directions for the future
Full article: Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease
Associations Between Obesity and the Effectiveness of Anti–Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta-analysis - Zhang-han Dai, Xi-tao Xu, Zhi-hua Ran, 2020
Nutrients, Free Full-Text
Obesity May Up Odds of Anti-TNF Therapy Failure in Ulcerative Colitis - MPR
Molecular pathogenesis of inflammatory bowel disease: relevance for novel therapies
AHDB April 2014, Vol 7, No 2 by Dalia Buffery - Issuu
/cdn.vox-cdn.com/uploads/chorus_image/image/72616826/1628105845.0.jpg "NFL Week 1 TNF Best Bets: Odds, Predictions to Consider on DraftKings Sportsbook for Lions vs. Chiefs - DraftKings Network")
